AgriBusiness Financial Results

Neogen Corporation Reports Second Quarter Fiscal 2026 Results

Neogen® Corporation (NASDAQ: NEOG) has announced a new partnership with Biomatter, a company specializing in enzyme design.

Key Takeaways:

  • Neogen Corporation Q2 revenues declined 2.8 percent year over year, while core revenue increased 2.9 percent.
  • Net loss narrowed significantly compared to the prior-year period due to the absence of a goodwill impairment charge.
  • Food Safety segment posted modest revenue growth, while Animal Safety revenues declined primarily due to divestitures.
  • The company raised its full-year fiscal 2026 revenue and Adjusted EBITDA outlook.

Neogen Corporation Reports Second Quarter Financial Performance

Neogen Corporation (NASDAQ: NEOG) announced financial results for the second quarter ended November 30, 2025. Revenues for the quarter were $224.7 million, a decrease of 2.8 percent compared to $231.3 million in the prior-year period. Core revenue, which excludes the effects of foreign currency, divestitures, and discontinued product lines, increased by 2.9 percent.

Net loss for the quarter was $15.9 million, or $(0.07) per diluted share, compared to a net loss of $456.3 million, or $(2.10) per diluted share, in the prior-year period. The improvement reflected the absence of a non-cash goodwill impairment charge recorded in the prior year. Adjusted net income was $22.6 million, or $0.10 per diluted share, compared to $24.4 million, or $0.11 per diluted share, a year earlier.

Gross margin was 47.5 percent, down from 49.0 percent in the same quarter last year, primarily due to tariff costs, inventory write-offs, and product mix. Adjusted EBITDA totaled $48.7 million, representing a margin of 21.7 percent, compared to $51.4 million and a margin of 22.2 percent in the prior-year period.

Leave a Reply